You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML-CP, AP

Showing 26 - 50 of 2,480
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 15, 2022

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid

Recruiting
  • CML-CP; Mutation;Suboptimal Response or Failure in TKI
  • Wuhan, Hubei, China
    Weiming Li
May 31, 2021

Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

Recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Birmingham, Alabama
  • +25 more
Jan 10, 2023

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia
    • Montréal, Quebec, Canada
    • +25 more
    Jul 25, 2022

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

    Recruiting
    • Healthy (For Part A)
    • Chronic Myeloid Leukemia (for Part B and C)
    • Vodobatinib (K0706) capsules
    • Downey, California
    • +69 more
    Dec 7, 2022

    Early Conversion of Dasatinib in CML-CP Patients

    Enrolling by invitation
    • Validity and Safety
    • Dasatinib 100 MG
    • Guangzhou, Guangdong, China
      NanfangH
    Dec 9, 2020

    Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory Trial in Worldwide (Radotinib HCl)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Radotinib HCl
    • Uijeongbu-si, Gyeonggi-do, Korea, Republic of
    • +17 more
    Jan 3, 2022

    Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Chronic Phase Chronic Myeloid Leukemia
    • Duarte, California
    • +27 more
    Dec 7, 2021

    Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase

    Recruiting
    • CML, Chronic Phase; TKI
    • Flumatinib Mesylate
    • Nilotinib Pill
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Feb 1, 2021

    CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

    Recruiting
    • CML, Chronic Phase
    • Flumatinib mesylate tablets (400mg)
    • Flumatinib mesylate tablets (600mg)
    • Harbin, Hei Longjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    Apr 28, 2022

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      Relationship of CP and AP

      Completed
      • Chronic Pancreatitis
      • Acute Pancreatitis
      • patients' characteristics
      • (no location specified)
      Dec 15, 2020

      Periapical Periodontitis Trial in Istanbul (Apical periodontitis)

      Completed
      • Periapical Periodontitis
      • Apical periodontitis
      • Istanbul, Esenler, Turkey
        Istanbul Medipol University, Faculty of Dentistry
      Sep 4, 2023

      Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

      Completed
      Has Results
      • Chronic Myeloid Leukemia
      • Ph+ Acute Lymphoblastic Leukemia
      • St Leonards, New South Wales, Australia
      • +41 more
      Jan 18, 2021

      Obesity, Childhood Trial in Taichung (L. rhamnosus bv-77, B. animalis subsp. lactis CP-9 and L. salivarius AP-32 mix probiotics

      Active, not recruiting
      • Obesity, Childhood
      • L. rhamnosus bv-77, B. animalis subsp. lactis CP-9 and L. salivarius AP-32 mix probiotics powder
      • Placebo
      • Taichung, Taiwan
        China Medical University Hospital
      Mar 7, 2022

      Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

      Active, not recruiting
      Has Results
      • Chronic Myelogenous Leukemia
      • Chicago, Illinois
      • +87 more
      Jan 20, 2023

      Myeloid Leukemia, Philadelphia Positive Trial in Worldwide (Asciminib Pediatric formulation group, Asciminib Adult formulation

      Recruiting
      • Myeloid Leukemia, Philadelphia Positive
      • Asciminib Pediatric formulation group
      • Asciminib Adult formulation group
      • Boston, Massachusetts
      • +24 more
      Jan 17, 2023

      Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

      Active, not recruiting
      Has Results
      • Myeloid Leukemia, Chronic, Chronic Phase
      • Atlanta, Georgia
      • +85 more
      Jan 4, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Beijing, China
        Peking University People's Hospital(北京大学人民医院)
      Jan 3, 2022

      Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

      Recruiting
      • Philadelphia Chromosome Positive CML
      • BCR-ABL Positive Chronic Myelogenous Leukemia
      • Amiens, France
      • +27 more
      Dec 9, 2021

      Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      • Chronic Myelogenous Leukemia
      • Amman, Jordan
      • +4 more
      Jan 17, 2022

      CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

      Active, not recruiting
      • Chronic Myeloid Leukemia
        • Saint-Pierre, Reunion, France
        • +39 more
        Dec 13, 2021